A new trading day began on Tuesday, with Rani Therapeutics Holdings Inc (NASDAQ: RANI) stock price down -4.12% from the previous day of trading, before settling in for the closing price of $1.94. RANI’s price has ranged from $0.39 to $3.87 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 4.78% over the past five years. Meanwhile, its annual earnings per share averaged 59.52%. With a float of $89.72 million, this company’s outstanding shares have now reached $97.54 million.
Rani Therapeutics Holdings Inc (RANI) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Rani Therapeutics Holdings Inc is 8.02%, while institutional ownership is 13.55%. The most recent insider transaction that took place on Oct 23 ’25, was worth 1,260,417. In this transaction Director of this company bought 2,083,334 shares at a rate of $0.60, taking the stock ownership to the 2,083,334 shares. Before that another transaction happened on Oct 21 ’25, when Company’s 10% Owner sold 4,000,000 for $2.77, making the entire transaction worth $11,074,000. This insider now owns 2,379,194 shares in total.
Rani Therapeutics Holdings Inc (RANI) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.16 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 59.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 35.44% during the next five years compared to 4.78% growth over the previous five years of trading.
Rani Therapeutics Holdings Inc (NASDAQ: RANI) Trading Performance Indicators
Here are Rani Therapeutics Holdings Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.26. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 188.34.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.79, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach -0.27 in one year’s time.
Technical Analysis of Rani Therapeutics Holdings Inc (RANI)
Rani Therapeutics Holdings Inc (NASDAQ: RANI) saw its 5-day average volume 3.78 million, a negative change from its year-to-date volume of 5.89 million. As of the previous 9 days, the stock’s Stochastic %D was 13.86%.
During the past 100 days, Rani Therapeutics Holdings Inc’s (RANI) raw stochastic average was set at 42.29%, which indicates a significant increase from 36.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.3435 in the past 14 days, which was higher than the 0.1486 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2024, while its 200-day Moving Average is $0.9810. Nevertheless, the first resistance level for the watch stands at $1.9566 in the near term. At $2.0532, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.1265. If the price goes on to break the first support level at $1.7867, it is likely to go to the next support level at $1.7134. The third support level lies at $1.6168 if the price breaches the second support level.
Rani Therapeutics Holdings Inc (NASDAQ: RANI) Key Stats
With a market capitalization of 226.01 million, the company has a total of 121,512K Shares Outstanding. Currently, annual sales are 1,030 K while annual income is -30,020 K. The company’s previous quarter sales were 0 K while its latest quarter income was -6,690 K.
